MTCR Chart
- 52-Week Range: $0.37 - $4.45
- Market Capitalization: $18.13M
- Short Percentage: 0%
- Target Price: $1.00
- Shares Outstanding: 42.16M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MTCR released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Metacrine Updates IBD Clinical Development Strategy and Implements Restructuring PlanGlobeNewsWire | February 11th
- 3 Penny Stocks To Watch After Jerome Powell's Fed AnnouncementPennyStocks | December 15th
- Metacrine Achieves Full Enrollment for MET642 Phase 2a Trial in Patients With NashGlobeNewsWire | September 9th
- Metacrine to Host Virtual R&D Day for Analysts and Investors on September 15, 2021GlobeNewsWire | September 8th
- Metacrine to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire | September 7th
- Metacrine Updates MET642 Clinical Development Milestone and Reports Second-Quarter 2021 ResultsGlobeNewsWire | August 12th
- Metacrine and Its Partners to Present Data at the EASL International Liver Congressâ„¢ 2021GlobeNewsWire | June 17th
Company Info
Website: https://www.metacrine.com
Address: 3985 Sorrento Valley Boulevard, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 32
Address: 3985 Sorrento Valley Boulevard, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 32
$MTCR This is just getting warmed up.
$MTCR the redness has arrived
$MTCR make it rain
let’s see some green
$MTCR we back
$MTCR we need one good push to moon this.
$MTCR It’s that TIME!! To Double down!
$MTCR i like the stock
$MTCR taking off soon
$MTCR prepare your cash to buy dip
$MTCR Let’s goooo